Bausch Health Companies Inc. Amortization of Debt Issuance Costs and Discounts
Bausch Health Companies Inc. (BHC) reported Amortization of Debt Issuance Costs and Discounts of $35.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-07-30
- Bausch Health Companies Inc. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $21.00M, a 48.78% decline year-over-year.
- Bausch Health Companies Inc. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $14.00M, a 6.67% decline year-over-year.
- Bausch Health Companies Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $22.00M, a 57.14% increase year-over-year.
- Bausch Health Companies Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $16.00M, a 23.08% increase year-over-year.
- Bausch Health Companies Inc. amortization of debt issuance costs and discounts for fiscal 2025 was $94.00M, a 70.91% increase from fiscal 2024.
- Bausch Health Companies Inc. amortization of debt issuance costs and discounts for fiscal 2024 was $55.00M, a 15.38% decline from fiscal 2023.
- Bausch Health Companies Inc. amortization of debt issuance costs and discounts for fiscal 2023 was $65.00M, a 34.34% decline from fiscal 2022.
- Bausch Health Companies Inc. amortization of debt issuance costs and discounts for fiscal 2022 was $99.00M, a 80.00% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 3 month as first filed | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 6 month as first filed | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month | Amortization of Debt Issuance Costs and Discounts 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $35.00M 10-Q · filed 2026-07-30 | $57.00M derived: sum of 3 quarters · filed 2026-07-30 | $73.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $14.00M 10-Q · filed 2026-04-30 | $36.00M derived: sum of 2 quarters · filed 2026-04-30 | $52.00M derived: sum of 3 quarters · filed 2026-04-30 | $93.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $38.00M derived: sum of 2 quarters · filed 2026-02-19 | $79.00M derived: sum of 3 quarters · filed 2026-07-30 | $94.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $57.00M derived: sum of 2 quarters · filed 2026-07-30 | $72.00M 10-Q · filed 2025-10-30 | $86.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $41.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $56.00M 10-Q · filed 2026-07-30 | $70.00M derived: sum of 3 quarters · filed 2026-07-30 | $83.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $15.00M 10-Q · filed 2026-04-30 | $29.00M derived: sum of 2 quarters · filed 2026-04-30 | $42.00M derived: sum of 3 quarters · filed 2026-04-30 | $56.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $27.00M derived: sum of 2 quarters · filed 2026-02-19 | $41.00M derived: sum of 3 quarters · filed 2026-02-19 | $55.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $27.00M derived: sum of 2 quarters · filed 2025-10-30 | $41.00M 10-Q · filed 2025-10-30 | $55.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $28.00M 10-Q · filed 2025-07-31 | $42.00M derived: sum of 3 quarters · filed 2026-02-19 | $70.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $14.00M 10-Q · filed 2025-05-01 | $28.00M derived: sum of 2 quarters · filed 2026-02-19 | $56.00M derived: sum of 3 quarters · filed 2026-02-19 | $68.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $42.00M derived: sum of 2 quarters · filed 2026-02-19 | $54.00M derived: sum of 3 quarters · filed 2026-02-19 | $65.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $40.00M derived: sum of 2 quarters · filed 2024-10-31 | $51.00M 10-Q · filed 2024-10-31 | $64.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $23.00M 10-Q · filed 2024-08-01 | $36.00M derived: sum of 3 quarters · filed 2025-02-20 | $58.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $11.00M 10-Q · filed 2024-05-02 | $24.00M derived: sum of 2 quarters · filed 2025-02-20 | $46.00M derived: sum of 3 quarters · filed 2025-02-20 | $96.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $35.00M derived: sum of 2 quarters · filed 2025-02-20 | $85.00M derived: sum of 3 quarters · filed 2025-02-20 | $99.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $72.00M derived: sum of 2 quarters · filed 2023-11-02 | $86.00M 10-Q · filed 2023-11-02 | $99.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $64.00M 10-Q · filed 2023-08-03 | $77.00M derived: sum of 3 quarters · filed 2024-02-22 | $94.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $14.00M 10-Q · filed 2023-05-04 | $27.00M derived: sum of 2 quarters · filed 2024-02-22 | $44.00M derived: sum of 3 quarters · filed 2024-02-22 | $56.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $30.00M derived: sum of 2 quarters · filed 2024-02-22 | $42.00M derived: sum of 3 quarters · filed 2024-02-22 | $55.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $29.00M derived: sum of 2 quarters · filed 2022-11-03 | $42.00M 10-Q · filed 2022-11-03 | $58.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $25.00M 10-Q · filed 2022-08-09 | $41.00M derived: sum of 3 quarters · filed 2023-02-23 | $54.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $13.00M 10-Q · filed 2022-05-10 | $29.00M derived: sum of 2 quarters · filed 2023-02-23 | $42.00M derived: sum of 3 quarters · filed 2023-02-23 | $59.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $29.00M derived: sum of 2 quarters · filed 2023-02-23 | $46.00M derived: sum of 3 quarters · filed 2023-02-23 | $61.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $30.00M derived: sum of 2 quarters · filed 2021-11-02 | $45.00M 10-Q · filed 2021-11-02 | $59.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $32.00M 10-Q · filed 2021-08-03 | $46.00M derived: sum of 3 quarters · filed 2022-05-11 | $63.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $15.00M 10-Q · filed 2021-05-04 | $29.00M derived: sum of 2 quarters · filed 2022-05-11 | $46.00M derived: sum of 3 quarters · filed 2022-05-11 | $61.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $14.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $31.00M derived: sum of 2 quarters · filed 2022-05-11 | $46.00M derived: sum of 3 quarters · filed 2022-05-11 | $63.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $32.00M derived: sum of 2 quarters · filed 2020-11-03 | $49.00M 10-Q · filed 2020-11-03 | $66.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $32.00M 10-Q · filed 2020-08-06 | $49.00M derived: sum of 3 quarters · filed 2021-05-04 | $67.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $17.00M 10-Q · filed 2020-05-07 | $34.00M derived: sum of 2 quarters · filed 2021-05-04 | $52.00M derived: sum of 3 quarters · filed 2021-05-04 | $73.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $17.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $35.00M derived: sum of 2 quarters · filed 2021-05-04 | $56.00M derived: sum of 3 quarters · filed 2021-05-04 | $79.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $39.00M derived: sum of 2 quarters · filed 2019-11-04 | $62.00M 10-Q · filed 2019-11-04 | $113.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $44.00M 10-Q · filed 2019-08-06 | $95.00M derived: sum of 3 quarters · filed 2020-02-19 | $129.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $23.00M 10-Q · filed 2019-05-06 | $74.00M derived: sum of 2 quarters · filed 2020-02-19 | $108.00M derived: sum of 3 quarters · filed 2020-02-19 | $131.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $85.00M derived: sum of 2 quarters · filed 2020-02-19 | $108.00M derived: sum of 3 quarters · filed 2020-02-19 | $151.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $34.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $57.00M derived: sum of 2 quarters · filed 2018-11-06 | $100.00M 10-Q · filed 2018-11-06 | $129.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $66.00M 10-Q · filed 2018-08-07 | $95.00M derived: sum of 3 quarters · filed 2019-02-20 | $127.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $43.00M 10-Q · filed 2018-05-08 | $72.00M derived: sum of 2 quarters · filed 2019-02-20 | $104.00M derived: sum of 3 quarters · filed 2019-02-20 | $140.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $61.00M derived: sum of 2 quarters · filed 2019-02-20 | $97.00M derived: sum of 3 quarters · filed 2019-02-20 | $118.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $32.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $68.00M derived: sum of 2 quarters · filed 2017-11-07 | $89.00M 10-Q · filed 2017-11-07 | $89.20M 10-Q · filed 2016-11-09 | $110.30M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $57.00M 10-Q · filed 2017-08-08 | $56.60M 10-Q · filed 2016-08-09 | $78.30M derived: sum of 3 quarters · filed 2018-08-10 | $98.80M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $21.00M 10-Q · filed 2017-05-09 | $20.50M 10-Q · filed 2016-06-07 | $42.30M derived: sum of 2 quarters · filed 2018-08-10 | $62.80M derived: sum of 3 quarters · filed 2018-08-10 | $155.50M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $21.30M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $41.80M derived: sum of 2 quarters · filed 2018-08-10 | $134.50M derived: sum of 3 quarters · filed 2018-08-10 | $145.00M 8-K · filed 2018-08-10 | $145.30M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $20.50M 10-Q · filed 2015-10-26 | $113.20M derived: sum of 2 quarters · filed 2015-10-26 | $123.70M 10-Q · filed 2016-11-09 | $135.60M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $92.70M 10-Q · filed 2015-07-28 | $103.20M 10-Q · filed 2016-08-09 | $115.10M derived: sum of 3 quarters · filed 2017-03-01 | $149.70M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $10.50M 10-Q · filed 2016-06-07 | $22.40M derived: sum of 2 quarters · filed 2017-03-01 | $57.00M derived: sum of 3 quarters · filed 2017-03-01 | $68.30M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $46.50M derived: sum of 2 quarters · filed 2017-03-01 | $57.80M derived: sum of 3 quarters · filed 2017-03-01 | $70.00M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $34.60M 10-Q · filed 2015-10-26 | $45.90M derived: sum of 2 quarters · filed 2015-10-26 | $58.10M 10-Q · filed 2015-10-26 | $77.10M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $11.30M 10-Q · filed 2015-07-28 | $23.50M 10-Q · filed 2015-07-28 | $42.50M derived: sum of 3 quarters · filed 2016-04-29 | $70.10M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $12.20M 10-Q · filed 2015-04-30 | $31.20M derived: sum of 2 quarters · filed 2016-04-29 | $58.80M derived: sum of 3 quarters · filed 2016-04-29 | $92.10M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $46.60M derived: sum of 2 quarters · filed 2016-04-29 | $79.90M derived: sum of 3 quarters · filed 2016-04-29 | $89.50M 10-K · filed 2016-04-29 | $89.46M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $27.60M 10-Q · filed 2014-10-24 | $27.57M 10-Q · filed 2013-11-01 | $60.90M derived: sum of 2 quarters · filed 2014-10-24 | $70.50M 10-Q · filed 2014-10-24 | $70.50M 10-Q · filed 2013-11-01 | $92.56M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $33.30M 10-Q · filed 2014-08-01 | $33.28M 10-Q · filed 2013-08-07 | $42.90M 10-Q · filed 2014-08-01 | $42.93M 10-Q · filed 2013-08-07 | $64.97M derived: sum of 3 quarters · filed 2015-02-25 | $73.94M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $9.60M 10-Q · filed 2014-05-09 | $9.65M 10-Q · filed 2013-05-03 | $31.66M derived: sum of 2 quarters · filed 2015-02-25 | $40.64M derived: sum of 3 quarters · filed 2015-02-25 | $40.25M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $22.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $31.04M derived: sum of 2 quarters · filed 2015-02-25 | $30.65M derived: sum of 3 quarters · filed 2015-02-25 | $36.40M 10-K · filed 2015-02-25 | $36.40M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $8.98M 10-Q · filed 2013-11-01 | $8.59M derived: sum of 2 quarters · filed 2013-11-01 | $14.34M 10-Q · filed 2013-11-01 | $22.41M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$391.00K 10-Q · filed 2013-08-07 | $5.36M 10-Q · filed 2013-08-07 | $13.43M derived: sum of 3 quarters · filed 2014-02-28 | $26.11M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $5.75M 10-Q · filed 2013-05-03 | $13.82M derived: sum of 2 quarters · filed 2014-02-28 | $26.50M derived: sum of 3 quarters · filed 2014-02-28 | $28.92M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $8.07M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $20.75M derived: sum of 2 quarters · filed 2014-02-28 | $23.17M derived: sum of 3 quarters · filed 2014-02-28 | $27.10M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $12.69M 10-Q · filed 2012-11-05 | $15.10M derived: sum of 2 quarters · filed 2012-11-05 | $19.03M 10-Q · filed 2012-11-05 | |||||
| 2011-06-30 | $2.41M 10-Q · filed 2012-08-03 | $6.35M 10-Q · filed 2012-08-03 | ||||||
| 2010-12-31 | $21.47M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |